References
- Tian R, Chang L, Liu D, et al. Association of the modified creatinine index with muscle strength and mortality in patients undergoing hemodialysis. Ren Fail. 2022;44(1):1732–1742.
- Canaud B, Granger Vallée A, Molinari N, et al. Creatinine index as a surrogate of lean body mass derived from urea Kt/V, pre-dialysis serum levels and anthropometric characteristics of haemodialysis patients. PLoS One. 2014;9(3):e93286.
- Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2.
- Bataille S, Serveaux M, Carreno E, et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36(6):1654–1660.
- Kim JK, Kim SG, Oh JE, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2019;34(3):599–607.
- Yajima T, Arao M, Yajima K, et al. The associations of fat tissue and muscle mass indices with all-cause mortality in patients undergoing hemodialysis. PLoS One. 2019;14(2):e0211988.
- Yajima T, Arao M, Yajima K, et al. Usefulness of computed tomography-measured psoas muscle thickness per height for predicting mortality in patients undergoing hemodialysis. Sci Rep. 2021;11(1):19070.
- Yajima T. Skeletal muscle density measured by computed tomography as a predictor of mortality in patients receiving hemodialysis. J Nephrol. 2022;35(5):1535–1537.
- Yajima T, Arao M, Yajima K. Psoas muscle index and psoas muscle density as predictors of mortality in patients undergoing hemodialysis. Sci Rep. 2022;12(1):10496.